Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	DrugBank	Drug (Description in trials)	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Bezafibrate	[10] Bezafibrate; Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour udca therapy; Bezafibrate (drug); Bezafibrate (inn 3968); Bezafibrate 200 mg; Bezafibrate 400 mg; Bezafibrate ir; Bezafibrate sr; Bezafibrate, beza, bzf, bezalip; Bezafibrate, beza, bzf, bezalip mono;	[1] D01366 💬	[1] PPARA 💬	[8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway	[6] 20, 93, 94, 160, 316, 324 💬
2	Glycerin	[2] Glycerine; Other: glycerine gel;	[1] D00028 💬	-	-	[6]  6 , 13, 79, 265, 316, 317 💬
3	Heparin	[9] Alkalinized lidocaine-heparin; Bladder instillation with heparin/ lidocaine; Device: heparin-induced extracorporeal ldl precipitation; Heparin; Heparin & alkalinized lidocaine bladder instillation; Heparin 25mg inhalation powder, hard capsule; Heparin sodium; Intralipid/heparin; Low molecular weight heparin calcium injection;	[1] D07510 💬	[1] SERPINC1 💬	[1] Complement and coagulation cascades	[11] 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317 💬
4	Levocarnitine	[4] Levocarnitine; Levocarnitine propyl hydrochloride; Valproate, levocarnitine; Valproic acid and levocarnitine;	[3] D02030 D02176 D04713 💬	-	-	[10]  3 ,  5 , 13, 53, 58, 96, 97, 265, 298, 316 💬